BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30529765)

  • 1. Polygenic risk for schizophrenia and associated brain structural changes: A systematic review.
    van der Merwe C; Passchier R; Mufford M; Ramesar R; Dalvie S; Stein DJ
    Compr Psychiatry; 2019 Jan; 88():77-82. PubMed ID: 30529765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measures.
    Harris MA; Shen X; Cox SR; Gibson J; Adams MJ; Clarke TK; Deary IJ; Lawrie SM; McIntosh AM; Whalley HC
    Psychol Med; 2020 Jul; 50(10):1653-1662. PubMed ID: 31317844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
    Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
    J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of polygenic risk scores to identify phenotypes associated with genetic risk of schizophrenia: Systematic review.
    Mistry S; Harrison JR; Smith DJ; Escott-Price V; Zammit S
    Schizophr Res; 2018 Jul; 197():2-8. PubMed ID: 29129507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic risk score for schizophrenia is more strongly associated with ancestry than with schizophrenia.
    Curtis D
    Psychiatr Genet; 2018 Oct; 28(5):85-89. PubMed ID: 30160659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk.
    Alnæs D; Kaufmann T; van der Meer D; Córdova-Palomera A; Rokicki J; Moberget T; Bettella F; Agartz I; Barch DM; Bertolino A; Brandt CL; Cervenka S; Djurovic S; Doan NT; Eisenacher S; Fatouros-Bergman H; Flyckt L; Di Giorgio A; Haatveit B; Jönsson EG; Kirsch P; Lund MJ; Meyer-Lindenberg A; Pergola G; Schwarz E; Smeland OB; Quarto T; Zink M; Andreassen OA; Westlye LT;
    JAMA Psychiatry; 2019 Jul; 76(7):739-748. PubMed ID: 30969333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for polygenic effects in genome-wide association studies.
    Pan W; Chen YM; Wei P
    Genet Epidemiol; 2015 May; 39(4):306-16. PubMed ID: 25847094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia polygenic risk scores, clinical variables and genetic pathways as predictors of phenotypic traits of bipolar I disorder.
    Grigoroiu-Serbanescu M; van der Veen T; Bigdeli T; Herms S; Diaconu CC; Neagu AI; Bass N; Thygesen J; Forstner AJ; Nöthen MM; McQuillin A
    J Affect Disord; 2024 Jul; 356():507-518. PubMed ID: 38640977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving polygenic prediction in ancestrally diverse populations.
    Ruan Y; Lin YF; Feng YA; Chen CY; Lam M; Guo Z; ; He L; Sawa A; Martin AR; Qin S; Huang H; Ge T
    Nat Genet; 2022 May; 54(5):573-580. PubMed ID: 35513724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
    Pardiñas AF; Smart SE; Willcocks IR; Holmans PA; Dennison CA; Lynham AJ; Legge SE; Baune BT; Bigdeli TB; Cairns MJ; Corvin A; Fanous AH; Frank J; Kelly B; McQuillin A; Melle I; Mortensen PB; Mowry BJ; Pato CN; Periyasamy S; Rietschel M; Rujescu D; Simonsen C; St Clair D; Tooney P; Wu JQ; Andreassen OA; Kowalec K; Sullivan PF; Murray RM; Owen MJ; MacCabe JH; O'Donovan MC; Walters JTR; ; Ajnakina O; Alameda L; Barnes TRE; Berardi D; Bonora E; Camporesi S; Cleusix M; Conus P; Crespo-Facorro B; D'Andrea G; Demjaha A; Do KQ; Doody GA; Eap CB; Ferchiou A; Di Forti M; Guidi L; Homman L; Jenni R; Joyce EM; Kassoumeri L; Khadimallah I; Lastrina O; Muratori R; Noyan H; O'Neill FA; Pignon B; Restellini R; Richard JR; Schürhoff F; Španiel F; Szöke A; Tarricone I; Tortelli A; Üçok A; Vázquez-Bourgon J
    JAMA Psychiatry; 2022 Mar; 79(3):260-269. PubMed ID: 35019943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: A systematic review.
    Mistry S; Harrison JR; Smith DJ; Escott-Price V; Zammit S
    J Affect Disord; 2018 Jul; 234():148-155. PubMed ID: 29529547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of schizophrenia polygenic risk and cortisol level on pre-adolescent brain structure.
    Bolhuis K; Tiemeier H; Jansen PR; Muetzel RL; Neumann A; Hillegers MHJ; van den Akker ETL; van Rossum EFC; Jaddoe VWV; Vernooij MW; White T; Kushner SA
    Psychoneuroendocrinology; 2019 Mar; 101():295-303. PubMed ID: 30599318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between early life complications and a polygenic risk score for schizophrenia is associated with brain activity during emotion processing in healthy participants.
    Toro VD; Antonucci LA; Quarto T; Passiatore R; Fazio L; Ursini G; Chen Q; Masellis R; Torretta S; Sportelli L; Kikidis GC; Massari F; D'Ambrosio E; Rampino A; Pergola G; Weinberger DR; Bertolino A; Blasi G
    Psychol Med; 2024 Jun; 54(8):1876-1885. PubMed ID: 38305128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited Evidence for Association of Genome-Wide Schizophrenia Risk Variants on Cortical Neuroimaging Phenotypes.
    Voineskos AN; Felsky D; Wheeler AL; Rotenberg DJ; Levesque M; Patel S; Szeszko PR; Kennedy JL; Lencz T; Malhotra AK
    Schizophr Bull; 2016 Jul; 42(4):1027-36. PubMed ID: 26712857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic overlap between epilepsy and schizophrenia: Evidence from cross phenotype analysis in Hong Kong Chinese population.
    Gui H; Li M; Sham PC; Baum L; ; Kwan P; Cherny SS
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):86-92. PubMed ID: 29150900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic scores for psychiatric disorders in a diverse postmortem brain tissue cohort.
    Duncan L; Shen H; Schulmann A; Li T; Kolachana B; Mandal A; Feng N; Auluck P; Marenco S
    Neuropsychopharmacology; 2023 Apr; 48(5):764-772. PubMed ID: 36694041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leveraging correlations between variants in polygenic risk scores to detect heterogeneity in GWAS cohorts.
    Yuan J; Xing H; Lamy AL; ; Lencz T; Pe'er I
    PLoS Genet; 2020 Sep; 16(9):e1009015. PubMed ID: 32956347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk score for five major psychiatric disorders associated with volume of distinct brain regions in the general population.
    Wang Z; Liu C; Dong Q; Xue G; Chen C
    Biol Psychol; 2023 Mar; 178():108530. PubMed ID: 36858107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia polygenic risk score predicts mnemonic hippocampal activity.
    Chen Q; Ursini G; Romer AL; Knodt AR; Mezeivtch K; Xiao E; Pergola G; Blasi G; Straub RE; Callicott JH; Berman KF; Hariri AR; Bertolino A; Mattay VS; Weinberger DR
    Brain; 2018 Apr; 141(4):1218-1228. PubMed ID: 29415119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between polygenic risk for schizophrenia, neurocognition and social cognition across development.
    Germine L; Robinson EB; Smoller JW; Calkins ME; Moore TM; Hakonarson H; Daly MJ; Lee PH; Holmes AJ; Buckner RL; Gur RC; Gur RE
    Transl Psychiatry; 2016 Oct; 6(10):e924. PubMed ID: 27754483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.